Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06384924 · ClinicalTrials.gov registry record
Raman Spectroscopy and Skin Cancer
A clinical trial of Squamous Cell Carcinoma and Skin Cancer, sponsored by Renee Farrell.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06384924 is a study of Squamous Cell Carcinoma and Skin Cancer that is actively recruiting participants, run by Renee Farrell. The registered enrollment target is 20 participants, below the 104-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06384924, a study of Squamous Cell Carcinoma and Skin Cancer, is actively recruiting participants, sponsored by Renee Farrell.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to find out if Raman Spectroscopy, a type of imaging, can be used to determine the size of skin cancer tumors. The main question it aims to answer is: -Can Raman Spectroscopy help figure out how far a tumor spreads? This study will take measurements using laser light from an experimental, handheld probe by lightly touching the skin.
Conditions Studied
Interventions
- DEVICE Raman Spectroscopy handheld probe (EmVision, FL, USA)
- DEVICE Raman Spectroscopy laser source (Hubner Photonics Inc, CA, USA)
Study Locations (1)
New York
- Stony Brook Hospital - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2027-02-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06384924
The ClinicalTrials.gov registry entry for NCT06384924 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 104-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (81% lower). The listed sponsor is Renee Farrell, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Squamous Cell Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Raman Spectroscopy handheld probe (EmVision, FL, USA) is the first listed.
NCT06384924 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06384924 about?
NCT06384924 is a clinical study titled "Raman Spectroscopy and Skin Cancer". The goal of this observational study is to find out if Raman Spectroscopy, a type of imaging, can be used to determine the size of skin cancer tumors. The main question it aims to answer is: -Can Raman Spectroscopy help figure out how far a tumor spreads? This study will take measurements using la...
What is the current status of trial NCT06384924?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-02-13. Estimated completion is 2027-02-13.
What conditions does trial NCT06384924 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma, Skin Cancer, Basal Cell Carcinoma.
What interventions are being tested in trial NCT06384924?
The interventions under investigation include: Raman Spectroscopy handheld probe (EmVision, FL, USA) (DEVICE), Raman Spectroscopy laser source (Hubner Photonics Inc, CA, USA) (DEVICE).
Who is sponsoring clinical trial NCT06384924?
This trial is sponsored by Renee Farrell, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06384924 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
RECRUITING · Phase 2
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
RECRUITING · NA
-
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
RECRUITING · Phase 2
-
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
RECRUITING · Phase 1
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Toripalimab With Chemotherapy for Sinus Cancer
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.